Delivery Order SPE2DB20D3303-SPE2DB26FY2P9
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Cephalexin 500 mg capsules (500-count units) valued at $2,322.83. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and requires ultimate completion by August 7, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,087.30 to AmerisourceBergen Drug Corp for the supply of Cephalexin 500 mg capsules (500-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a fulfillment under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cephalexin 500 mg capsules (500-count) under a firm fixed-price contract with a ceiling value of $3,027.14. The award, issued on October 28, 2025, with an ultimate completion date of October 29, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for Cephalexin 250 mg capsules in quantities of 500 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,456.96 and is scheduled for completion by August 11, 2025. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,609.79 to AmerisourceBergen Drug Corp for 500 mg Cephalexin capsules (500-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance...
- The Defense Logistics Agency awarded a $1,141.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 capsules of Cephalexin 500 mg, a commonly prescribed antibiotic medication. The contract was competitively awarded without set-aside designation and is scheduled for completion by October 24, 2025. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Cephalexin 100ml, with a contract ceiling value of $3,361.64 and a firm fixed price structure. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Cephalexin Capsules, valued at $12,321.33 with a firm fixed price structure. This non-set-aside contract is scheduled for completion by October 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,386,917 units of the pharmaceutical product Cephalexin 250 mg Capsule 500s. The $1,103.85 order has a completion date of January 22, 2024 and was awarded on January 20, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contracts from DLA to provide pharmaceuticals,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Cephalexin 250 mg/5 mL suspension in 100 mL quantities, with a ceiling value of $4,224.34. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 12,...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB26FY2P9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Cephalexin 500 mg capsules (500-count units) under a firm fixed-price contract valued at $1,512.34. This is a non-set-aside competitive award with an ultimate completion date of November 12, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026 that serves as the primary vehicle for pharmaceutical and medical supply procurement supporting military healthcare systems. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, maintains a substantial federal contracting portfolio with the Defense Logistics Agency focused on delivering critical medications and medical supplies to military and veteran healthcare programs. The company's federal contract awards demonstrate consistent capability in fulfilling competitive procurement requirements across diverse therapeutic categories, including antibiotics such as this cephalosporin product. As a child contract under the DLA Troop Support Medical IDC, this delivery order exemplifies the flexible procurement mechanism that enables rapid fulfillment of pharmaceutical needs across the Defense Health Agency and other federal healthcare entities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/10/25 |